Gender Dysphoria and Gender Reassignment Surgery | UHC Coverage Update

TL;DR: UnitedHealthcare modified its Medicare Advantage coverage policy for gender dysphoria and gender reassignment surgery, effective November 2, 2025. Here's what billing teams need to know before submitting claims.

UnitedHealthcare updated its Medicare Advantage medical policy governing gender dysphoria and gender reassignment surgery. This policy covers 146 CPT codes across female-to-male procedures (including CPT 55980, 58150, and 19303), male-to-female procedures (including CPT 55970, 57291, and 54520), and ancillary services. Coverage determinations under this policy flow through Medicare Administrative Contractors on a case-by-case basis — which means your billing team needs to know exactly which MAC governs your region before submitting a claim.

Quick-Reference Table

UnitedHealthcare Gender Reassignment Surgery Coverage Criteria and Medical Necessity Requirements 2025

The UnitedHealthcare gender reassignment surgery coverage policy under Medicare Advantage does not operate on a single national standard. CMS conducted a National Coverage Analysis and explicitly declined to issue a National Coverage Determination (NCD) for gender reassignment surgery under NCD 140.9. That decision pushes all coverage determinations to local Medicare Administrative Contractors.

This matters for your billing team in a direct, practical way. Medical necessity decisions for CPT codes like 55980 (intersex surgery, female to male) and 55970 (intersex surgery, male to female) are made by your regional MAC — not by UnitedHealthcare centrally, and not by CMS nationally. If your MAC has issued a Local Coverage Determination (LCD) or Local Coverage Article (LCA), that LCD governs. UnitedHealthcare's policy states that compliance with applicable LCDs and LCAs is required.

If your state or territory has no LCD or LCA in place, UnitedHealthcare directs you to its Commercial Medical Policy titled Gender Dysphoria Treatment for coverage guidelines. That's a separate policy document, and your billing team should pull it before submitting claims for Medicare Advantage members in LCD-absent jurisdictions.

Cross-sex hormone therapy adds another layer. It may be covered as part of gender dysphoria treatment, but Part B vs. Part D coverage rules apply. Whether a hormone is billed under Part B (outpatient medical benefit) or Part D (pharmacy benefit) determines which claim form, which payer pathway, and which prior authorization process applies. Get this wrong and you're looking at a claim denial before the clinical question is even raised.

Prior authorization requirements are not stated universally in this policy — they are LCD-dependent. Check your MAC's LCD for prior auth requirements before scheduling or billing any procedure in this code set.

Coverage Indications at a Glance

UnitedHealthcare Gender Reassignment Surgery Billing Guidelines and Action Items 2025

This policy became effective November 2, 2025. If your team hasn't reviewed its billing workflow against this update, do it now.

CPT, HCPCS, and ICD-10 Codes for Gender Reassignment Surgery Under gender-dysphoria-gender-reassignment-surgery

Female-to-Male Procedure CPT Codes

Male-to-Female Procedure CPT Codes

Other Ancillary Services CPT Codes

Note: The full policy includes 146 CPT codes total. The policy data provided lists the codes above. For the complete code set, access the full policy at PayerPolicy.org.

Key ICD-10-CM Diagnosis Codes

The policy data does not list specific ICD-10-CM codes. Confirm applicable diagnosis codes through your regional MAC's LCD or LCA for gender dysphoria and gender reassignment surgery.

The Real Issue with This Coverage Policy

The MAC-by-MAC structure of this coverage policy is the biggest operational risk for billing teams. There is no single medical necessity standard. Reimbursement outcomes depend entirely on which MAC covers your jurisdiction and what that MAC's LCD says.

That fragmentation creates real exposure. A procedure covered under one MAC's LCD may not be covered under another's. If your practice operates across multiple states, you need a separate LCD review for each jurisdiction. This isn't a theoretical problem — it's how claim denial happens on high-cost surgical claims.

The ancillary code set also deserves scrutiny. Dermabrasion (CPT 15780–15783), chemical peels (CPT 15788–15793), blepharoplasty (CPT 15820–15823), and rhytidectomy (CPT 15824–15826) carry high cosmetic-procedure denial risk when billed without strong LCD support. These codes appear in the policy, but appearing in a policy is not the same as being covered. Your MAC's LCD determines whether any specific ancillary procedure clears medical necessity review.

If your billing team spans multiple MAC jurisdictions, loop in your compliance officer before the effective date of November 2, 2025 to build a jurisdiction-by-jurisdiction coverage matrix.